Logo image of LRN

STRIDE INC (LRN) Stock Fundamental Analysis

USA - NYSE:LRN - US86333M1080 - Common Stock

140.87 USD
+2.33 (+1.68%)
Last: 9/18/2025, 7:00:00 PM
140.87 USD
0 (0%)
After Hours: 9/18/2025, 7:00:00 PM
Fundamental Rating

7

We assign a fundamental rating of 7 out of 10 to LRN. LRN was compared to 74 industry peers in the Diversified Consumer Services industry. LRN scores excellent points on both the profitability and health parts. This is a solid base for a good stock. LRN is not priced too expensively while it is growing strongly. Keep and eye on this one! This makes LRN very considerable for growth and quality investing!


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

LRN had positive earnings in the past year.
In the past year LRN had a positive cash flow from operations.
Each year in the past 5 years LRN has been profitable.
LRN had a positive operating cash flow in each of the past 5 years.
LRN Yearly Net Income VS EBIT VS OCF VS FCFLRN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

1.2 Ratios

LRN has a Return On Assets of 12.55%. This is amongst the best in the industry. LRN outperforms 90.54% of its industry peers.
Looking at the Return On Equity, with a value of 19.46%, LRN belongs to the top of the industry, outperforming 85.14% of the companies in the same industry.
LRN has a Return On Invested Capital of 15.98%. This is amongst the best in the industry. LRN outperforms 93.24% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for LRN is above the industry average of 9.88%.
The last Return On Invested Capital (15.98%) for LRN is above the 3 year average (11.97%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 12.55%
ROE 19.46%
ROIC 15.98%
ROA(3y)10.13%
ROA(5y)8.29%
ROE(3y)16.74%
ROE(5y)14.46%
ROIC(3y)11.97%
ROIC(5y)10.27%
LRN Yearly ROA, ROE, ROICLRN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

With a decent Profit Margin value of 11.97%, LRN is doing good in the industry, outperforming 71.62% of the companies in the same industry.
LRN's Profit Margin has improved in the last couple of years.
With an excellent Operating Margin value of 17.44%, LRN belongs to the best of the industry, outperforming 81.08% of the companies in the same industry.
LRN's Operating Margin has improved in the last couple of years.
LRN's Gross Margin of 39.24% is in line compared to the rest of the industry. LRN outperforms 44.59% of its industry peers.
In the last couple of years the Gross Margin of LRN has grown nicely.
Industry RankSector Rank
OM 17.44%
PM (TTM) 11.97%
GM 39.24%
OM growth 3Y23.39%
OM growth 5Y41.07%
PM growth 3Y23.52%
PM growth 5Y38.44%
GM growth 3Y3.53%
GM growth 5Y3.28%
LRN Yearly Profit, Operating, Gross MarginsLRN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

8

2. Health

2.1 Basic Checks

LRN has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
The number of shares outstanding for LRN has been increased compared to 1 year ago.
LRN has more shares outstanding than it did 5 years ago.
The debt/assets ratio for LRN has been reduced compared to a year ago.
LRN Yearly Shares OutstandingLRN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M
LRN Yearly Total Debt VS Total AssetsLRN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

2.2 Solvency

An Altman-Z score of 7.32 indicates that LRN is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 7.32, LRN belongs to the best of the industry, outperforming 93.24% of the companies in the same industry.
The Debt to FCF ratio of LRN is 1.35, which is an excellent value as it means it would take LRN, only 1.35 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of LRN (1.35) is better than 85.14% of its industry peers.
A Debt/Equity ratio of 0.31 indicates that LRN is not too dependend on debt financing.
LRN has a Debt to Equity ratio of 0.31. This is comparable to the rest of the industry: LRN outperforms 50.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF 1.35
Altman-Z 7.32
ROIC/WACC1.96
WACC8.17%
LRN Yearly LT Debt VS Equity VS FCFLRN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B

2.3 Liquidity

LRN has a Current Ratio of 5.39. This indicates that LRN is financially healthy and has no problem in meeting its short term obligations.
LRN has a Current ratio of 5.39. This is amongst the best in the industry. LRN outperforms 94.59% of its industry peers.
A Quick Ratio of 5.27 indicates that LRN has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 5.27, LRN belongs to the best of the industry, outperforming 94.59% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 5.39
Quick Ratio 5.27
LRN Yearly Current Assets VS Current LiabilitesLRN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

7

3. Growth

3.1 Past

LRN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 28.91%, which is quite impressive.
LRN shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 58.07% yearly.
LRN shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 17.90%.
The Revenue has been growing by 18.24% on average over the past years. This is quite good.
EPS 1Y (TTM)28.91%
EPS 3Y33.5%
EPS 5Y58.07%
EPS Q2Q%-27.46%
Revenue 1Y (TTM)17.9%
Revenue growth 3Y12.56%
Revenue growth 5Y18.24%
Sales Q2Q%22.36%

3.2 Future

Based on estimates for the next years, LRN will show a very strong growth in Earnings Per Share. The EPS will grow by 22.40% on average per year.
Based on estimates for the next years, LRN will show a quite strong growth in Revenue. The Revenue will grow by 9.06% on average per year.
EPS Next Y31.37%
EPS Next 2Y23.22%
EPS Next 3Y22.4%
EPS Next 5YN/A
Revenue Next Year12.47%
Revenue Next 2Y10.05%
Revenue Next 3Y9.78%
Revenue Next 5Y9.06%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
LRN Yearly Revenue VS EstimatesLRN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B
LRN Yearly EPS VS EstimatesLRN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2 4 6 8 10

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 23.40, which indicates a rather expensive current valuation of LRN.
Based on the Price/Earnings ratio, LRN is valued a bit cheaper than 66.22% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.41, LRN is valued at the same level.
With a Price/Forward Earnings ratio of 17.81, LRN is valued on the expensive side.
LRN's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. LRN is cheaper than 71.62% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of LRN to the average of the S&P500 Index (22.88), we can say LRN is valued slightly cheaper.
Industry RankSector Rank
PE 23.4
Fwd PE 17.81
LRN Price Earnings VS Forward Price EarningsLRN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

LRN's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. LRN is cheaper than 71.62% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of LRN indicates a somewhat cheap valuation: LRN is cheaper than 78.38% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 16.49
EV/EBITDA 10.03
LRN Per share dataLRN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The excellent profitability rating of LRN may justify a higher PE ratio.
LRN's earnings are expected to grow with 22.40% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.75
PEG (5Y)0.4
EPS Next 2Y23.22%
EPS Next 3Y22.4%

0

5. Dividend

5.1 Amount

No dividends for LRN!.
Industry RankSector Rank
Dividend Yield N/A

STRIDE INC

NYSE:LRN (9/18/2025, 7:00:00 PM)

After market: 140.87 0 (0%)

140.87

+2.33 (+1.68%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)08-05 2025-08-05/amc
Earnings (Next)10-20 2025-10-20/amc
Inst Owners108.35%
Inst Owner Change-0.75%
Ins Owners2.68%
Ins Owner Change2.73%
Market Cap6.15B
Analysts83.64
Price Target170.13 (20.77%)
Short Float %8.84%
Short Ratio5.35
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-21.01%
Min EPS beat(2)-41.53%
Max EPS beat(2)-0.5%
EPS beat(4)2
Avg EPS beat(4)73.2%
Min EPS beat(4)-41.53%
Max EPS beat(4)331.54%
EPS beat(8)6
Avg EPS beat(8)57.76%
EPS beat(12)9
Avg EPS beat(12)17.68%
EPS beat(16)12
Avg EPS beat(16)16.02%
Revenue beat(2)2
Avg Revenue beat(2)3.14%
Min Revenue beat(2)2.93%
Max Revenue beat(2)3.34%
Revenue beat(4)4
Avg Revenue beat(4)4.15%
Min Revenue beat(4)2.13%
Max Revenue beat(4)8.2%
Revenue beat(8)7
Avg Revenue beat(8)3.01%
Revenue beat(12)11
Avg Revenue beat(12)2.73%
Revenue beat(16)15
Avg Revenue beat(16)3.37%
PT rev (1m)2.67%
PT rev (3m)2.67%
EPS NQ rev (1m)-0.22%
EPS NQ rev (3m)6.37%
EPS NY rev (1m)5.64%
EPS NY rev (3m)6.31%
Revenue NQ rev (1m)0.63%
Revenue NQ rev (3m)3.47%
Revenue NY rev (1m)3.81%
Revenue NY rev (3m)3.81%
Valuation
Industry RankSector Rank
PE 23.4
Fwd PE 17.81
P/S 2.56
P/FCF 16.49
P/OCF 14.2
P/B 4.15
P/tB 5.69
EV/EBITDA 10.03
EPS(TTM)6.02
EY4.27%
EPS(NY)7.91
Fwd EY5.61%
FCF(TTM)8.54
FCFY6.07%
OCF(TTM)9.92
OCFY7.04%
SpS55.13
BVpS33.91
TBVpS24.77
PEG (NY)0.75
PEG (5Y)0.4
Profitability
Industry RankSector Rank
ROA 12.55%
ROE 19.46%
ROCE 21.07%
ROIC 15.98%
ROICexc 31.63%
ROICexgc 52.41%
OM 17.44%
PM (TTM) 11.97%
GM 39.24%
FCFM 15.5%
ROA(3y)10.13%
ROA(5y)8.29%
ROE(3y)16.74%
ROE(5y)14.46%
ROIC(3y)11.97%
ROIC(5y)10.27%
ROICexc(3y)20.97%
ROICexc(5y)16.99%
ROICexgc(3y)36.26%
ROICexgc(5y)30.39%
ROCE(3y)15.79%
ROCE(5y)13.55%
ROICexcg growth 3Y30.19%
ROICexcg growth 5Y48.22%
ROICexc growth 3Y36.36%
ROICexc growth 5Y54.51%
OM growth 3Y23.39%
OM growth 5Y41.07%
PM growth 3Y23.52%
PM growth 5Y38.44%
GM growth 3Y3.53%
GM growth 5Y3.28%
F-Score7
Asset Turnover1.05
Health
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF 1.35
Debt/EBITDA 0.86
Cap/Depr 52.33%
Cap/Sales 2.49%
Interest Coverage 45.89
Cash Conversion 81.02%
Profit Quality 129.47%
Current Ratio 5.39
Quick Ratio 5.27
Altman-Z 7.32
F-Score7
WACC8.17%
ROIC/WACC1.96
Cap/Depr(3y)56.69%
Cap/Depr(5y)59.43%
Cap/Sales(3y)3.07%
Cap/Sales(5y)3.32%
Profit Quality(3y)114.14%
Profit Quality(5y)117.4%
High Growth Momentum
Growth
EPS 1Y (TTM)28.91%
EPS 3Y33.5%
EPS 5Y58.07%
EPS Q2Q%-27.46%
EPS Next Y31.37%
EPS Next 2Y23.22%
EPS Next 3Y22.4%
EPS Next 5YN/A
Revenue 1Y (TTM)17.9%
Revenue growth 3Y12.56%
Revenue growth 5Y18.24%
Sales Q2Q%22.36%
Revenue Next Year12.47%
Revenue Next 2Y10.05%
Revenue Next 3Y9.78%
Revenue Next 5Y9.06%
EBIT growth 1Y68.1%
EBIT growth 3Y38.88%
EBIT growth 5Y66.8%
EBIT Next Year43.28%
EBIT Next 3Y22.23%
EBIT Next 5Y18.08%
FCF growth 1Y71.64%
FCF growth 3Y38.85%
FCF growth 5Y60.14%
OCF growth 1Y55.24%
OCF growth 3Y27.9%
OCF growth 5Y40.03%